Please login to the form below
COVID-19 vaccines
This page shows the latest COVID-19 vaccines news and features for those working in and with pharma, biotech and healthcare.
GSK and GCOA report reveals global inequities in adult immunisation uptake
The new data reveals the varying uses of vaccines within a single city and ways to advance equitable access to adult immunisation. ... race. A previous GSK-funded analysis of global vaccine trends by the IQVIA Institute revealed that approximately 100
Latest news
-
Researchers improve understanding of COVID-19 virus and future variants
The study aims to contribute to the design of future COVID-19 vaccines and drugs. ... The SARS-CoV-2 virus, which is responsible for the COVID-19 pandemic, along with other viruses, genetically mutate throughout their lifecycle.
-
Alliance for mRNA Medicines launched to accelerate global innovation
The potential of the approach was brought to the fore during the COVID-19 pandemic and mRNA vaccines, including those from Moderna and Pfizer/BioNTech, have now been used globally to ... Beyond COVID-19, the flexibility and speed with which mRNA vaccines
-
University of Oxford launches new trial to enhance flu and COVID-19 vaccines
The Oxford Vaccine Group at the University of Oxford has launched a new vaccine trial to enhance the design of both influenza and COVID-19 vaccines. ... Participants will receive two vaccines: an mRNA COVID-19 booster vaccine and a seasonal flu jab.
-
AstraZeneca studies highlight burden of COVID-19 for immunocompromised
Additionally, as with other vaccines, COVID-19 vaccines are not as effective in IC individuals due to an inability to produce a robust protective response to the vaccine. ... The results from the studies revealed that, despite receiving repeated doses of
-
Differences in immune responses could optimise future COVID-19 vaccines
19. Vaccines provide individuals with immunity without risking the disease or its complications. ... These results give us a deep understanding of how we might optimise the design of COVID-19 booster vaccines in the future,” said Professor Derek Smith,
More from news
Approximately 6 fully matching, plus 262 partially matching documents found.
Latest Intelligence
-
Turning the UK into an mRNA superpower: what would it take?
New vaccines can be rapidly designed, quickly adapted to address specific viruses and manufactured at scale – nearly seven billion mRNA vaccines were made for COVID-19 last year alone. ... The country had successes in accelerating COVID-19 vaccines. It
-
The rise of biologics: is the sector ready for future demand?
While global regulatory agencies have focused much of their attention on approving COVID-19 tests and vaccines for use over the last few years, now the focus is shifting to other ... A shift in the focus of regulatory agencies from COVID-19 tests and
-
A new age of innovation in healthcare
It is also important to ensure that the short-term reputational gains from creating and manufacturing COVID-19 vaccines is not lost over time.
-
Future-proofing pharma supply chains by improving inefficiencies in global health architecture
But as we have seen with COVID-19, the risks are very real. ... The international R&D effort to find experimental treatments and vaccines for COVID-19 has been laudable, given its novel nature and urgency.
-
FlyPharma Europe unites pharma, biotech and bio pharma with air cargo logistics
viral vector vaccines against COVID-19. ... Key topics. One of the key topics on FlyPharma Europe’s agenda this year is COVID-19 challenges and opportunities.
More from intelligence
Approximately 0 fully matching, plus 19 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
25. 5. It's bridging the gender data gap. As we mentioned in our recent blog ‘Why the COVID-19 vaccines are a women’s health issue’, there is a concerning ... MobiHealthNews. Published August 12, 2021. Accessed November 4, 2021. Nearly two million
-
How scientific storytelling can help Pharma cut through the noise
This again can be particularly powerful for comparisons of risk – such as the risk of adverse side effects from Covid-19 vaccines.
-
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving ... COVID-19 has prompted an interest in microbiology,
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
2. Andrews N, et al.Impact of COVID-19 Vaccines on Mortality in England.London; 2021. ... https://www.health.harvard.edu/blog/why-are-mrna-vaccines-so-exciting-2020121021599. Accessed June 10, 2021. 7. Understanding Viral Vector COVID-19 Vaccines.
-
Vaccine hesitancy eBook
Today, all eyes are on vaccines. At its high, the US administered 3.4 million doses of the COVID-19 vaccines per day, but in April, this number dwindled ... The motivations behind the Arm in Arm campaign, a global campaign designed to encourage
More from PMHub
Approximately 0 fully matching, plus 17 partially matching documents found.
Subscribe to our email news alerts
- HCP ENGAGEMENT STUDY: Pharma shifts top priority to HCP insights and impact metrics
- AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer
- BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer
- Stanford Medicine researchers find blood tests help predict organ failure
- GSK and GCOA report reveals global inequities in adult immunisation uptake
- A “Leaky Pipeline” and the Loss of Talented Female Physicians
No results were found
PMHub
BOLDSCIENCE
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
